Acoustic neuroma, also known as vestibular schwannoma, is a noncancerous tumor that develops on the vestibular nerve, which connects the inner ear to the brain. Several companies are involved in the research, development, and production of medical devices and technologies related to the diagnosis and treatment of acoustic neuromas.
SonoCure Secured CHF 16 million (€18 million) in funding to advance its SonoPhore®️ ultrasound tumor ablation technology for treating acoustic neuromas. This minimally invasive technique holds promise for reducing treatment risks and preserving hearing.
OncoBelgian Launched Phase 2b clinical trials evaluating the efficacy of OB-003, a targeted therapy, for treating acoustic neuromas. This personalized approach could offer improved treatment outcomes compared to traditional options.
AiCure Debuted its AI-powered surgical navigation assistant, enhancing visualization and targeting accuracy during acoustic neuroma surgery, potentially leading to more complete tumor removal and minimizing nerve damage
UT Southwestern Medical Center Pioneered a minimally invasive ear-canal approach for extracting acoustic neuromas. This technique reduces trauma and scarring compared to traditional skull-based surgery, offering faster recovery and improved patient experience.
List of Acoustic Neuroma Key Companies in the Market
Acoustic Neuroma Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)